Mireille Van Gele
Overview
Explore the profile of Mireille Van Gele including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
843
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Desmet E, Bracke S, Forier K, Taevernier L, Stuart M, De Spiegeleer B, et al.
Int J Pharm
. 2016 Jan;
500(1-2):268-74.
PMID: 26806466
RNA interference (RNAi) is a rapidly emerging approach for targeted gene silencing to alleviate disease pathology. However, lack of efficient carriers for targeted delivery delays the clinical translation of RNAi....
12.
Chevolet I, Schreuer M, Speeckaert R, Neyns B, Hoorens I, van Geel N, et al.
Melanoma Res
. 2015 Jun;
25(4):357-61.
PMID: 26050145
Interferon-α (IFN-α) is the only approved adjuvant treatment for high-risk melanoma patients in Europe, but the impact on overall survival is low. Although it is believed that IFN-α exerts its...
13.
Van Bockstal M, Lambein K, Van Gele M, De Vlieghere E, Limame R, Braems G, et al.
Oncoscience
. 2015 Jan;
1(10):634-48.
PMID: 25593993
Cancer progression is characterized by a complex reciprocity between neoplastic epithelium and adjacent stromal cells. In ductal carcinoma in situ (DCIS) of the breast, both reduced stromal decorin expression and...
14.
Chevolet I, Speeckaert R, Schreuer M, Neyns B, Krysko O, Bachert C, et al.
J Transl Med
. 2015 Jan;
13:9.
PMID: 25592374
Background: Immune markers in the peripheral blood of melanoma patients could provide prognostic information. However, there is currently no consensus on which circulating cell types have more clinical impact. We...
15.
De Ryck T, Grootaert C, Jaspaert L, Kerckhof F, Van Gele M, De Schrijver J, et al.
Appl Microbiol Biotechnol
. 2014 Jun;
98(15):6831-46.
PMID: 24917376
Crosstalk between the human host and its microbiota is reported to influence various diseases such as mucositis. Fundamental research in this area is however complicated by the time frame restrictions...
16.
Speeckaert R, Van Gele M, Speeckaert M, Lambert J, van Geel N
Pigment Cell Melanoma Res
. 2014 Mar;
27(4):512-24.
PMID: 24612852
Hyperpigmentation is a key feature in a variety of inherited and acquired syndromes. Nonetheless, determining the exact diagnosis only on the clinical phenotype can be challenging, and a detailed search...
17.
Bustin S, Benes V, Garson J, Hellemans J, Huggett J, Kubista M, et al.
Nat Methods
. 2013 Nov;
10(11):1063-7.
PMID: 24173381
Two surveys of over 1,700 publications whose authors use quantitative real-time PCR (qPCR) reveal a lack of transparent and comprehensive reporting of essential technical information. Reporting standards are significantly improved...
18.
Callewaert C, Kerckhof F, Granitsiotis M, Van Gele M, Van de Wiele T, Boon N
PLoS One
. 2013 Aug;
8(8):e70538.
PMID: 23950955
The skin microbial community is regarded as essential for human health and well-being, but likewise plays an important role in the formation of body odor in, for instance, the axillae....
19.
Dynoodt P, Speeckaert R, de Wever O, Chevolet I, Brochez L, Lambert J, et al.
Int J Oncol
. 2013 Feb;
42(4):1443-51.
PMID: 23404256
MicroRNAs (miRNAs) are post-transcriptional modulators of gene expression which play important roles in tumorigenesis and cancer metastasis. Since they are often highly deregulated in various types of cancer, miRNAs may...
20.
Speeckaert R, van Geel N, Lambert J, Boone B, Chevolet I, Van Gele M, et al.
Oncoimmunology
. 2012 Jul;
1(4):526-528.
PMID: 22754773
Insights into immune reactions against benign and malignant melanocytes may help the development of more efficient immunotherapeutic treatments for melanoma. The interplay between an active systemic antitumor immunity and a...